Early therapeutic interventions in inflammatory rheumatic diseases have proven successful in inducing drug-free remission, and EULAR...

As biosimilars continue to gain acceptance and adoption in rheumatology, clinicians can optimise treatment strategies, improve...

Gout is a chronic inflammatory process that requires lifelong treatment and is associated with an increased...

Axial spondyloarthritis (axSpA) is a systemic inflammatory form of arthritis that primarily affects the axial...

An Irish committee of rheumatology experts is coming together as part of a global initiative seeking...

The aim of this CPD module is to discuss the pathophysiology of rheumatoid arthritis (RA), diagnosis...

The biopsychosocial model of pain, where pain is affected not just by ‘physical’ factors, but also...

Welcome to the latest annual edition of Update Rheumatology and Pain. In this bumper issue we...

Many different agents are available to treat people with axSpA, but they do not always work...

An increased risk of adverse pregnancy and neonatal outcomes has been reported for pregnancies...

Three abstracts presented at the 2022 EULAR Congress shed new light on risk of a wide...

The British Society for Rheumatology (BSR) has launched a new guideline for the treatment of psoriatic...